Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Perez

Showing results (11-20 of 134) with videos related to

Pageof 14
Sort By:
Cancer|November 17, 2011
Mechanisms of resistance to vascular endothelial growth factor blockadeShaad E Abdullah, Roman Perez-Soler
Oncology (Williston Park, N.Y.)|December 25, 2007
Clinical research of EGFR inhibitors and related dermatologic toxicitiesRoman Perez-Soler, Eric Van Cutsem
Journal of Environmental Quality|October 27, 2020
Sources and priming of nitrous oxide production across a range of moisture contents in a soil with high organic matterCarmen C Roman-Perez, Guillermo Hernandez-Ramirez
Current Oncology Reports|December 6, 2001
Tyrosine kinase inhibitors: a clinical perspectiveSanjay Goel, Sridhar Mani, Roman Perez-Soler
Journal of Experimental Therapeutics & Oncology|November 28, 2007
EGFR inhibitor-mediated apoptosis in solid tumorsSanjay Goel, Manuel Hidalgo, Roman Perez-Soler
Drugs|March 1, 2014
Targeting angiogenesis in squamous non-small cell lung cancerBilal Piperdi, Amartej Merla, Roman Perez-Soler
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2008
RETRACTED: Tumor dependence on the EGFR signaling pathway expressed by the p-EGFR:p-AKT ratio predicts erlotinib sensitivity in human non-small cell lung cancer (NSCLC) cells expressing wild-type EGFR geneTianhong Li, Yi-He Ling, Roman Perez-Soler
Molecular Pharmacology|June 6, 2008
Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptorL858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAKYi-He Ling, Ruoping Lin, Roman Perez-Soler
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2007
Schedule-dependent interaction between the proteosome inhibitor bortezomib and the EGFR-TK inhibitor erlotinib in human non-small cell lung cancer cell linesBilal Piperdi, Yi-He Ling, Roman Perez-Soler
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2015
Mechanobioreactors for Cartilage Tissue EngineeringJoanna F Weber, Roman Perez, Stephen D Waldman
Pageof 14

Showing results (11-20 of 134) with videos related to

Sort By:
Pageof 14
Cancer|November 17, 2011
Mechanisms of resistance to vascular endothelial growth factor blockadeShaad E Abdullah, Roman Perez-Soler
Oncology (Williston Park, N.Y.)|December 25, 2007
Clinical research of EGFR inhibitors and related dermatologic toxicitiesRoman Perez-Soler, Eric Van Cutsem
Journal of Environmental Quality|October 27, 2020
Sources and priming of nitrous oxide production across a range of moisture contents in a soil with high organic matterCarmen C Roman-Perez, Guillermo Hernandez-Ramirez
Current Oncology Reports|December 6, 2001
Tyrosine kinase inhibitors: a clinical perspectiveSanjay Goel, Sridhar Mani, Roman Perez-Soler
Journal of Experimental Therapeutics & Oncology|November 28, 2007
EGFR inhibitor-mediated apoptosis in solid tumorsSanjay Goel, Manuel Hidalgo, Roman Perez-Soler
Drugs|March 1, 2014
Targeting angiogenesis in squamous non-small cell lung cancerBilal Piperdi, Amartej Merla, Roman Perez-Soler
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2008
RETRACTED: Tumor dependence on the EGFR signaling pathway expressed by the p-EGFR:p-AKT ratio predicts erlotinib sensitivity in human non-small cell lung cancer (NSCLC) cells expressing wild-type EGFR geneTianhong Li, Yi-He Ling, Roman Perez-Soler
Molecular Pharmacology|June 6, 2008
Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptorL858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAKYi-He Ling, Ruoping Lin, Roman Perez-Soler
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2007
Schedule-dependent interaction between the proteosome inhibitor bortezomib and the EGFR-TK inhibitor erlotinib in human non-small cell lung cancer cell linesBilal Piperdi, Yi-He Ling, Roman Perez-Soler
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2015
Mechanobioreactors for Cartilage Tissue EngineeringJoanna F Weber, Roman Perez, Stephen D Waldman
Pageof 14